(February 2020) “Q&A: The novel coronavirus outbreak causing COVID-19”, BMC Medicine18 (1), p. 57. doi:10.1186/s12916-020-01533-w.
(March 2020) “Comorbidities and multi-organ injuries in the treatment of COVID-19”, Lancet395 (10228), p. e52. doi:10.1016/s0140-6736(20)30558-4.
(March 2020) “Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures”, Journal of Medical Virology92 (6), p. 568–576. doi:10.1002/jmv.25748.
(May 2020) “Could nasal breathing help to mitigate the severity of COVID-19”, Microbes and Infection22 (4–5), p. 168–171. doi:10.1016/j.micinf.2020.05.002.
(March 2020) “Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence”, International Journal of Antimicrobial Agents55 (6), p. 105948. doi:10.1016/j.ijantimicag.2020.105948.
(November 2020) “Update to living WHO guideline on drugs for covid-19”, BMJ (Clinical Research Ed.)371, p. m4475. doi:10.1136/bmj.m4475. 227059995.
(April 2020) “COVID-19, ECMO, and lymphopenia: a word of caution”, The Lancet. Respiratory Medicine8 (4), p. e24. doi:10.1016/s2213-2600(20)30119-3.
(2021) “Immunopathogenesis and treatment of cytokine storm in COVID-19”, Theranostics11 (1), p. 316–329. doi:10.7150/thno.49713.
(December 2020) “Therapy for Early COVID-19: A Critical Need”, JAMA324 (21), p. 2149–2150. doi:10.1001/jama.2020.22813.
(November 2020) “Covid-19: What now for remdesivir?”, BMJ371, p. m4457. doi:10.1136/bmj.m4457.
(April 2020) “2019 Novel coronavirus: where we are and what we know”, Infection48 (2), p. 155–163. doi:10.1007/s15010-020-01401-y.